Hubei Biocause Pharmaceutical Co Ltd
000627
Company Profile
Business description
Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.
Contact
2nd Floor, Building 1, No. 1 Tianshan Road
Guohua Huijin Center
Zhanghe New District, Hubei Province
Jingmen448000
CHNT: +86 7246096558
Sector
Financial Services
Stock type
Cyclical
Industry
Insurance - Life
Fiscal Year End
31 December 2025
Employees
1,765
Stocks News & Analysis
stocks
A 5-Star US stock to buy with a near-5% yield - Clone
Undervalued by 23%, this cheap dividend stock is a top pick in its sector.
stocks
3 Warren Buffett stocks to avoid today
These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,079.20 | 17.70 | 0.20% |
| CAC 40 | 7,870.68 | 75.26 | 0.97% |
| DAX 40 | 23,739.47 | 204.64 | 0.87% |
| Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
| FTSE 100 | 9,284.83 | 70.85 | 0.77% |
| HKSE | 26,128.20 | 356.48 | -1.35% |
| NASDAQ | 22,484.07 | 99.37 | 0.44% |
| Nikkei 225 | 45,354.99 | 399.94 | -0.87% |
| NZX 50 Index | 13,111.73 | 42.06 | -0.32% |
| S&P 500 | 6,643.70 | 38.98 | 0.59% |
| S&P/ASX 200 | 8,787.70 | 13.20 | 0.15% |
| SSE Composite Index | 3,828.11 | 25.20 | -0.65% |